Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Diseases and Conditions
  3. Staphylococcus Aureus (S. Aureus or “staph”)
  4. Vancomycin Intermediate Staphylococcus Aureus (VISA) and Vancomycin Resistant Staphylococcus Aureus (VRSA)
Topic Menu

VISA and VRSA

  • VISA/VRSA Home
  • VISA/VRSA For Health Professionals

MRSA

  • MRSA Home
  • About MRSA
  •  -  CA-MRSA
  •  -  HA-MRSA
  • MRSA Surveillance and Reporting
  • MRSA Recommendations
  • MRSA Guidelines and Resources

VISA and VRSA

  • VISA/VRSA Home
  • VISA/VRSA For Health Professionals

MRSA

  • MRSA Home
  • About MRSA
  •  -  CA-MRSA
  •  -  HA-MRSA
  • MRSA Surveillance and Reporting
  • MRSA Recommendations
  • MRSA Guidelines and Resources
Contact Info
Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Contact Info

Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

VISA and VRSA Information for Health Professionals

On this page:
Reporting
Information for labs
Clinical Features 
Infection Prevention and Control Guidelines
 

Reporting VISA and VRSA

  • Reporting Staphylococcus aureus Infection
    Health care providers and clinical laboratories are required to report VISA and VRSA to the Minnesota Department of Health.

Information for labs

  • CDC: Laboratory Detection of Vancomycin-Intermediate/Resistant Staphylococcus aureus (VISA/VRSA)
    VISA and VRSA fact sheet for laboratories from the CDC.

Clinical features

  • Signs and symptoms
    The signs and symptoms of Staphylococcus aureus vary among individuals.  
    A person may not have all of these symptoms.

Infection Prevention and Control Guidelines

  • Infection Prevention and Control Guidelines
    General infection prevention guidelines, recommendations, and laws related to infection prevention.
Tags
  • staph
Last Updated: 05/21/2024

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube